Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Hope for painful skin condition: new drug trial launches

NCT ID NCT07492251

First seen Mar 26, 2026 · Last updated May 22, 2026 · Updated 11 times

Summary

This study tests a daily pill called upadacitinib for people with severe forms of lichen planus that affect the mouth, genitals, or scalp. The drug aims to calm the immune system and reduce pain, itching, and hair loss. About 56 adults will receive either the drug or a placebo for 16 weeks to see if it works and is safe.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LICHEN PENIS PLANUS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • APHP

    Paris, France

    Contact Email: •••••@•••••

    Contact Email: •••••@•••••

    Contact

  • CHU de Nice

    Nice, Alpes Maritimes, 06200, France

    Contact Email: •••••@•••••

    Contact

  • CHU de Rouen

    Rouen, France

    Contact Email: •••••@•••••

    Contact

  • CHU de Tours

    Tours, France

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Centre privé de Dermatologie

    Reims, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

Conditions

Explore the condition pages connected to this study.